Vnitr Lek 2020, 66(4):e51-e55 | DOI: 10.36290/vnl.2020.081

Long term use of the telemonitoring system Diani in the therapy of a patient with type 1 diabetes

Jan Brož1, Anna Holubová2,3, Jan Mužík2,3, Martina Vlasáková3,4, Miroslav Mužný2,3,4, Alice Králová5, Lucie Hoskovcová1, Denisa Janíčková Žďárská1, Eirik Arsand6,7, Michaela Hronová1,4, Jana Urbanová8, Milan Kvapil1
1 Interní klinika 2. LF UK a FN Motol Praha
2 Fakulta biomedicínského inženýrství ČVUT Praha
3 Centrum podpory aplikačních výstupů a spin‑off firem 1. LF UK Praha
4 1. LF UK Praha
5 Interní klinika FN Ostrava
6 Norwegian Centre for E‑Health Research, University Hospital of North Norway, Tromsø, Norway
7 Department of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway
8 II. interní klinika 3. LF UK a FNKV Praha

Mobile and wearable technologies offer patients with diabetes mellitus new possibilities for data collection and their more effective analysis. The Diabesdagboga smartphone application and the Diani web portal enable to collect and analyze glycaemia values, carbohydrates intake, insulin doses and the level of physical activity. The data are not only accessible in the corresponding smartphone but also automatically transferred to an Internet portal, where they may be completed by the records from an electronic pedometer and continuous glucose monitor. All these data may then be displayed in various types of graphical outputs and are available to both the patient and the physician. The case report of a patient who has used the system for almost two years shows a significant improvement in metabolic compensation (a decrease in the mean HbA1c value by 18.6 mmol/mol as compared with the previous period).

Keywords: diabetes diary, diabetes mellitus, HbA1c, hypoglycaemia, mobile application, telemedicine, telemonitoring, web application, web portal.

Published: June 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Brož J, Holubová A, Mužík J, Vlasáková M, Mužný M, Králová A, et al.. Long term use of the telemonitoring system Diani in the therapy of a patient with type 1 diabetes. Vnitr Lek. 2020;66(4):e51-55. doi: 10.36290/vnl.2020.081.
Download citation

References

  1. AbuDagga A, Resnick HE, Alwan M. Impact of blood pressure telemonitoring on hypertension outcomes: a literature review. Telemed J E Health 2010; 16: 830-838. Go to original source... Go to PubMed...
  2. Inglis SC, Clark RA, McAlister FA, et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev 2010; CD007228. Go to original source...
  3. McLean S, Chandler D, Nurmatov U, et al. Telehealthcare for asthma. Cochrane Database Syst Rev 2010; 10: CD007717. Go to original source... Go to PubMed...
  4. Brzan PP, Rotman E, Pajnkihar M, et al. Mobile Applications for Control and Self Management of Diabetes: A Systematic Review. J Med Syst 2016; 40: 210. Go to original source... Go to PubMed...
  5. Ramachandran A, Snehalatha C, Ram J, et al. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel‑group, randomised controlled trial. Lancet Diabetes Endocrinol 2013; 1: 191-198. Go to original source... Go to PubMed...
  6. Muzny M, Muzik J, Årsand E, et al. Experience with Design of a Smartwatch Diabetes Diary Application. International Journal on Biomedicine and Healthcare 2015; 3: 22-24.
  7. Muzik J, Broz J, Holubová A, et al. Telemedicine tools for automated generation of diabetes diary. Diabetes Technology & Therapeutics. February 2016, 18: A-1-A-140. Go to PubMed...
  8. Holubová, A, Janíčková Žďárská D, Oulická M, et al. Kroková zátěž u pacientů s diabetes mellitus 1. typu a hodnocení vlivu míry a intenzity chůze na hodnotu glykemie. DMEV 2015; 18: (Suppl. 1): 52-53.
  9. Muzik J, Broz J, Oulicka M, et al. Integration platform for diabetes related biosignals. Diabetes Technology & Therapeutics. February 2015, 17: (S1): A-1-A-180. Go to original source...
  10. Årsand E, Muzny M, Bradway M, et al. Performance of the first Combined Smartwatch/Smartphone Diabetes Diary Application Study. J Diabetes Sci Technol 2015; 9: 556-563. Go to original source... Go to PubMed...
  11. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994; 17: 697-703. Go to original source... Go to PubMed...
  12. Czupryniak L, Barkai L, Bolgarska S, et al. Self‑monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe--recommendations from the international Central‑Eastern European expert group. Diabetes Technol Ther 2014; 16: 460-475. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.